Macular Amyloidosis: A Case Report by Jaka Radoš et al.
138
Acta Dermatovenerol Croat                    2008; 16(3):138-141                         CASE REPORT
Macular Amyloidosis: A Case Report
Jaka Radoš, Sandra Marinović Kulišić, Jasna Lipozenčić, Dragomir Budimčić, 
Davorin Lončarić
University Department of Dermatology and Venereology, Zagreb University Hospital 
Center and School of Medicine, Zagreb, Croatia
Corresponding author:
Jaka Radoš, MD, MS
University Department of Dermatology  
and Venereology






Received: January 7, 2008
Accepted: April 2, 2008
SUMMARY Macular amyloidosis is a major cause of skin pigmentation 
and a rare form of localized primary cutaneous amyloidosis in western 
countries, with a higher prevalence in Asia and South America. The 
etiopathogenesis of macular amyloidosis has not yet been fully 
clarified; a number of risk factors are involved, among them chronic 
friction in particular. A 54-year-old patient with macular amyloidosis 
is presented. The diagnosis of macular amyloidosis was based on 
history data on long-term persistence of the disorder, localized pruritus 
and constant scratching urge, grayish-brown pigmentation over the 
scapula, and detection of amyloid in histologic slides. Three-month 
tretinoin therapy resulted in pruritus alleviation, with no change in the 
appearance of hyperpigmentation. The exact incidence of macular 
amyloidosis in Croatia is not known, however, the issue appears to be 
underestimated or neglected in dermatology routine.
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INTRODUCTION
Macular amyloidosis is a localized, primary 
form of cutaneous amyloidosis, which has been 
rarely tackled in western countries, probably be-
cause of its rather low prevalence. Clinically, it 
manifests with characteristic, readily recognizable 
brownish pigmentation mostly on the upper back 
(1). The disorder has been mostly described in 
Asia and in South and Central America, in women 
aged 40-70 (1).
Amyloid AK is exclusively accumulated in the 
skin (2). It may be difficult to detect on hematoxy-
lin-eosin stained histologic slides, thus requiring 
additional testing by use of histologic or immuno-
histochemical methods, or electron microscopy 
(2). The etiopathogenesis of the disease remains 
obscure; however, most authors tend to associate 
its onset to some form of mechanical trauma, con-
stant friction in particular (3-5). As amyloid depos-
its show high chemical resistance, all therapeutic 
approaches attempted to date have produced 
rather poor and only transient results (1).
We present a patient with a clinically charac-
teristic manifestation of macular amyloidosis, with 
the diagnosis made on the basis of history data 
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on long-term duration of the disease, clinical ap-
pearance of lesions and amyloid detected by skin 
histology. 
CASE REPORT
In May 2007, a 54-year-old man, otherwise 
healthy, presented to the Department outpatient 
clinic for dark skin pigmentation in the left scapular 
region. The pigmentation had developed 15 years 
before and gradually enlarged to the present size. 
The patient did not complain of any discomfort ex-
cept for pruritus in the region that used to intensify 
with warm weather. He could not recollect any in-
flammation at the site in the past. Dermatologic 
examination showed a grayish-brown pigmented 
area of irregular shape, 20x15 cm in size, of indis-
tinct margins on the skin over the left scapula and 
paravertebral region, with slightly reticular and 
ruffled surface (Fig. 1).
The patient complained of no discomforts or 
neurologic disturbances other than pruritus that 
made him rubbing every now and then the skin 
through the clothes or even scratching it with his 
nails. During the last year he was taking statins 
for elevated blood lipids. He denied any atopic 
disease, chronic disease, or similar lesions in his 
family history.
Diagnostic work-up revealed normal routine 
biochemistry findings except for elevated plasma 
triglycerides and cholesterol, normal electropho-
resis and immunoelectrophoresis, normal urine 
finding, negative urinary Bence-Jones protein, 
negative stool parasites, normal thyroid function 
tests and normal serum calcitonin and adrenal 
gland hormone levels, whereas x-ray of the spine 
showed no degenerative changes.
Histologic slides showed mild enlargement of 
dermal papillae containing a homogeneous, amor-
phous material corresponding to amyloid (Fig. 2). 
The presence of amyloid was confirmed by histo-
chemical Congo red stain, when amyloid stained 
light-red at the sites of accumulation. Melano-
phages and scant lymphohistiocytic infiltrate were 
found in papillary dermis.
The patient was recommended local applica-
tion of retinoids (Zorac gel, 0.01%). At 3-month fol-
low up visit, the lesion looked unchanged but the 
patient reported pruritus alleviation.
Figure 1. Poorly delineated, hyperpigmented 
patches with slightly rippled and reticulated sur-
faces on the skin of the upper back.
DISCUSSION
Amyloidosis is a group of rare disorders char-
acterized by the accumulation of fibrillar material 
(amyloid). Chemically, amyloid is not a uniform 
substance but a group of substances consisting 
of 16 different fibrillar proteins described to date 
(2). Primary cutaneous amyloidosis characterized 
by amyloid accumulation exclusively in the skin 
should be differentiated from systemic amyloido-
sis where amyloid is deposited in internal organs 
in addition to the skin (1,2). In primary cutaneous 
amyloidosis, mostly clinically represented by mac-
ular amyloidosis and lichen amyloidosis, amyloid 
AK originates from keratinocytes, i.e. from keratin 
intermediary filaments, as demonstrated by im-
munohistochemical studies (2,6). The presence of 
a typical clinical picture obviates the need of ex-
tensive diagnostic work-up to rule systemic amy-
loidosis out (7). In systemic amyloidosis, the pre-
cursor amyloid proteins are immunoglobulin light 
chains that are deposited in tissues in myelopro-
liferative diseases, multiple myeloma in particular 
Figure 2. Circumscribed deposit of amyloid is 
present in superficial dermis. Hyaline material is 
barely distinguishable from collagen. The diagno-
sis may be easily missed. There are some mela-
nophages in papillary dermis and scant lympho-
histiocytic infiltrate (HE stain, original magnifica-
tion X80).
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(2). In systemic amyloidosis associated with the 
presence of chronic diseases (e.g., rheumatoid 
arthritis, tuberculosis), the C-reactive protein-like 
amyloid AA produced from serum proteins is de-
posited in tissues (2). In systemic amyloidosis, 
when skin lesions suggestive of amyloidosis are 
absent, biopsy specimens are obtained from other 
sites (e.g., rectum, gingiva, abdominal subcutane-
ous fat or kidney) (7). 
Amyloidogenesis in macular amyloidosis de-
pends on a number of factors. Prolonged friction, 
atopy, itching, genetic predisposition, racial and fa-
milial factors, Epstein-Barr virus and environmen-
tal factors (humidity, temperature and light) have 
been reported as major etiological factors (8).
Most authors believe that localized trauma in 
the form of continuous friction, scratching or ma-
nipulation on taking bath or skin cleansing with the 
use of various gloves, sponges, brushes, plant 
stalks or leaves plays a role in the genesis of amy-
loid due to mechanical damage to keratinocytes 
or their apoptosis (3-5). It has been proposed that 
basal layer keratinocytes die due to apoptosis or 
release keratin bodies to the dermis, where they 
are lined with antikeratin antibodies. Upon being 
phagocytosed by macrophages, they are believed 
to take active part in the formation of AK, trans-
forming proteins with previously α structure into β 
pattern proteins (2-5). The disease has been de-
scribed by various terms such as friction melano-
sis, friction amyloidosis, macular amyloidosis and 
towel melanosis (5); all these authors emphasize 
the role of mechanical trauma in the disease on-
set. In their epidemiological study, Rasi et al. found 
no association between macular amyloidosis and 
friction but postulated the role of female hormones 
in the disease genesis because of its predominant 
occurrence in young age females (9). The asso-
ciation of macular amyloidosis with multiple endo-
crine neoplasia syndrome 2 (MEN2) was observed 
in some families (10). This hereditary syndrome 
includes some endocrine manifestations such as 
medullary thyroid carcinoma and pheochromo-
cytoma (10). On differential diagnosis, it may be 
difficult to discriminate residual hyperpigmenta-
tion and macular amyloidosis, or some forms of 
circumscribed atopic dermatitis, which may occa-
sionally precede the onset of macular amyloidosis 
(1). In these conditions, not only amyloid but also 
melanophages and scant inflammatory infiltration 
are found in histologic slides (2). Differentiation 
of notalgia paresthetica and macular amyloidosis 
may also pose a problem. In the former, sensory 
neuropathy usually induced by spinal nerve com-
pression due to degenerative changes of the spine 
(which results in hyperpigmentation of the skin in 
the dermatome innervated by the nerve involved) 
is regularly present in addition to hyperpigmenta-
tion on the back (11). Some authors consider no-
talgia paresthetica as a separate entity, whereas 
others believe that it is a transitory stage in the 
development of macular amyloidosis (1).
Therapeutic effects are only partial and short-
lasting (transient) because amyloid is hard to dis-
solve (1). Attempts can be made with moderate 
strength corticosteroids by use of occlusive tech-
nique or intralesional application (1). There are re-
ports on the beneficial effect of retinoids; however, 
data on long-term follow up are lacking (12). The 
mechanism of action of acitretin is not known. Ret-
inoids are strong inductors of apoptosis and can 
also stimulate macrophages for phagocytosis and 
elimination of amyloid AK deposits. These two ef-
fects may reduce the formation of amyloid (12).
In case of severe itching, distractors (mentho-
late lotions or creams) and capsaicin (which is ef-
ficacious in notalgia paresthetica) can be admin-
istered (1). In clinical studies, the effect of topical 
dimethyl sulfoxide (DMSO) was assessed in pa-
tients with persistent and unbearable itching. The 
mechanism of action of DMSO is explained by 
blockade of the nerve or mediators released from 
mastocytes. The mechanisms proposed may pre-
vent signal transfer in synapses to type C nerve 
fiber, thus causing interruption of the vicious circle 
of pruritus – amyloid deposition – pruritus (13). 
The opinions on therapeutic effects of DMSO are 
contradictory (13,14).
CONClUSION
Macular amyloidosis is a rare disease in Eu-
rope, however, with a slightly higher prevalence 
in Mediterranean countries, as evidenced by in-
dividual reports by Italian (3,5) and German (15) 
authors. In Croatia, exact data on the incidence of 
macular amyloidosis are lacking. The issue may 
have been underestimated in clinical routine since 
discoloration can be primarily considered as a 
cosmetic problem unless associated with severe 
itching, thus the problem proceeds unrecognized 
or neglected by dermatologists. In case of severe 
itching, the disease poses a serious therapeutic 
problem and challenge. Additional studies are def-
initely needed in the field of the disease etiopatho-
genesis. This case report may hopefully stimulate 
further studies of this intriguing disease in Croatia 
as a Mediterranean country.
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